Minor Use Minor Species Development of Drugs: Research Project Grant

by: TopGovernmentGrants Editorial Staff

The National Institutes of Health, more commonly referred to as NIH, is an agency operating under the United States Department of Health and Human Services that is primarily accountable for funding and supporting the nation's biomedical and health-related research studies.

The grants and programs of the NIH are all designed to contribute to the agency's general mission which is to "seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce the burdens of illness and disability."

In line with this mission, the National Institutes of Health has partnered with the U.S. Food and Drug Administration (FDA) and the Center for Veterinary Medicine(CVM) in an effort to establish the Minor Use Minor Species Development of Drugs: Research Project Grant.

The grant project seeks to solicit applications and proposals from eligible institutions and organizations who are willing to design and develop brand new animal drugs that are solely exclusive for minor use in major species or minor species.

In the year 2004, the The Minor Use and Minor Species Animal Health Act was constituted and this law enabled veterinarians to have legal access to more medications that are effective in the management and treatment of disease conditions that are common in minor animal species and minor uses in major animal species.

  (continued...)

Minor Use Minor Species Development of Drugs: Research Project Grant
  Page 2

About The Author The TopGovernmentGrants Editorial Staff maintains one the most comprehensive Websites offering information on government grants and federal government programs. The staff also provides resources to other Websites with information on philanthropy giving and community grants.

Additional Resources

category - Health Grants

Harnessing Advanced Health Technologies to Drive Mental Health Improvement Program
The National Institutes of Health has collaborated with National Institute of Mental Health (NIMH) in order to constitute the establishment of the Harnessing Advanced Health Technologies to Drive Mental Health Improvement Program.

---

Strategic Alliances for Medications Development to Treat Substance Use Disorder Program
The National Institutes of Health, in cooperation with the National Institute on Drug Abuse (NIDA), has recently established the Strategic Alliances for Medications Development to Treat Substance Use Disorder Program wherein both agencies seek to support the development of substance abuse drugs by leveraging the strengths of two or more organizations toward a common goal of medications development.

---

Pilot Surveillance System for High Impact/Low Prevalence Congenital and Inherited Conditions Program
The Centers for Disease Control and Prevention has recently established the Pilot Surveillance System for High Impact/Low Prevalence Congenital and Inherited Conditions Program wherein it seeks to create and evaluate a surveillance system for congenital and inherited disease conditions.

---

The Collaborative Islet Transplantation Registry Program
The National Institutes of Health has formed a partnership with the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) in order to establish the The Collaborative Islet Transplantation Registry Program wherein both agencies seek to invite applications that intend to continue initiatives started through the Collaborative Islet Transplantation Registry (CITR).

---